JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

Cassava Sciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

3.4 -5.82

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.35

Max

3.5300000000000002

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-21M

-44M

Pelno marža

-2,258.347

Darbuotojai

30

EBITDA

-21M

-45M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+123.46% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

75M

184M

Ankstesnė atidarymo kaina

9.22

Ankstesnė uždarymo kaina

3.4

Naujienos nuotaikos

By Acuity

50%

50%

176 / 373 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bearish Evidence

Cassava Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-29 23:28; UTC

Karštos akcijos

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

2025-10-29 23:07; UTC

Uždarbis

Prudential PLC 3Q New Business Profit Up 13%

2025-10-30 00:00; UTC

Uždarbis

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

2025-10-30 00:00; UTC

Uždarbis

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

2025-10-30 00:00; UTC

Uždarbis

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

2025-10-29 23:46; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

2025-10-29 23:40; UTC

Uždarbis

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

2025-10-29 23:38; UTC

Rinkos pokalbiai

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

2025-10-29 23:25; UTC

Uždarbis

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

2025-10-29 22:51; UTC

Uždarbis

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

2025-10-29 22:45; UTC

Uždarbis

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

2025-10-29 22:41; UTC

Uždarbis

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

2025-10-29 22:41; UTC

Uždarbis

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

2025-10-29 22:09; UTC

Uždarbis

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

2025-10-29 22:08; UTC

Rinkos pokalbiai
Uždarbis

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

2025-10-29 21:58; UTC

Uždarbis

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

2025-10-29 21:58; UTC

Uždarbis

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

2025-10-29 21:57; UTC

Uždarbis

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

2025-10-29 21:54; UTC

Uždarbis

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

2025-10-29 21:46; UTC

Uždarbis

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

2025-10-29 21:43; UTC

Uždarbis

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

2025-10-29 21:43; UTC

Uždarbis

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

2025-10-29 21:42; UTC

Uždarbis

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

2025-10-29 21:42; UTC

Uždarbis

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

2025-10-29 21:41; UTC

Uždarbis

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

2025-10-29 21:41; UTC

Uždarbis

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

2025-10-29 21:41; UTC

Uždarbis

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

2025-10-29 21:41; UTC

Uždarbis

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

2025-10-29 21:40; UTC

Uždarbis

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

2025-10-29 21:39; UTC

Uždarbis

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Akcijų palyginimas

Kainos pokytis

Cassava Sciences Inc Prognozė

Kainos tikslas

By TipRanks

123.46% į viršų

12 mėnesių prognozė

Vidutinis 8 USD  123.46%

Aukščiausias 8 USD

Žemiausias 8 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Cassava Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

1.56 / 1.7Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bearish Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

176 / 373 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
help-icon Live chat